Latest News
Mentari's $200M Private Placement Boosts InMed Merger Funding
InMed Pharmaceuticals (INM) shares rose 21% after Mentari Therapeutics revealed a $200M private placement, boosting total merger financing to $490M.
Zhongchao Stock Surges 456% in Trading Frenzy, Volume 57 Times Float
Zhongchao Inc. (ZCMD) stock rocketed 456% in heavy trading, with volume reaching 57 times its public float amid multiple trading halts.
Netflix Stock Gains on Record Buyback, Revenue Deceleration Raises Questions
Netflix shares climbed 2.2% on a record $4.7 billion buyback, but slowing revenue growth and a weaker Q3 forecast keep investors cautious.
Bitmine Buyback Boosts Ether Per Share, Driving Weekly Gains
Bitmine's latest share buyback drove a 1.05% Ether-per-share gain, with 88% from reduced share count. Stock rose 4.6% to $18.02.
Lakewood-Amedex Surges 143% on Nu-3 Update, Volume Explodes
Lakewood-Amedex shares jumped 143.5% on heavy volume after providing an update on its Nu-3 antibiotic program, though no new patient data was disclosed.
SK hynix Accelerates AI Packaging Spending After Stock Reverses Early Gains
SK hynix is speeding up AI packaging investment at its Cheongju P&T7 facility, approving 7.0931 trillion won, as shares closed lower after an early 9% rally. The move reflects rising capital spending on packaging alongside wafer production.
AMC Shares Rise Despite Dilution Outpacing EBITDA Growth
AMC shares climbed 7.5% early Wednesday, but the company's adjusted diluted share count expanded faster than its adjusted EBITDA growth, causing per-share metrics to decline.
Angelini Completes $4.1B Catalyst Buyout, Delists From Nasdaq
Angelini Pharma has finalized its $4.1 billion all-cash acquisition of Catalyst Pharmaceuticals, delisting the stock from Nasdaq. The deal reflects an enterprise value of about 5.1 times projected 2026 revenue.